USFDA conducts inspection at Alkem's Bioequivalence Center at Taloja; Stock rises

18 Apr 2022 , 10:25 AM

Alkem Laboratories Ltd has informed to the exchanges regarding USFDA Inspection at Alkem’s Bioequivalence Center at Taloja.

According to the regualtory filing, USFDA had conducted an inspection at the company’s Bioequivalence Center located at Taloja, Maharashtra from April 11-14, 2022.

Further, at the end of the inspection, no Form 483 was issued, said company.

On Monday, at around 10:27 AM, Alkem Laboratories was trading at Rs3,441.45 apiece up by Rs25.15 or 0.74% from its previous closing of Rs3,416.30 apiece on the BSE.